RA

Ronak Agrawal

Active Director Director DIN 10612219
DIN 10612219 First appointment May 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2024
Shareholding value •••• Premium profile

About Ronak Agrawal

Data last updated:

Ronak Agrawal is a Director at Aries Drugs Private Limited (since 2024) and Director at Gemcross Formulation Private Limited (since 2026). The companies operate in Healthcare. The largest current company by reported revenue is Aries Drugs Private Limited at ₹2.58 Cr (FY 2024).

DIN 10612219
Primary Designation Director
Industry Healthcare
First Appointment 02 May 2024
Oldest Company Age 21 yrs
Largest company Aries Drugs Private Limited · ₹2.58 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aries Drugs Private Limited U24232UR2005PTC007478
Director02 May 20242005₹2.58 Cr (FY 2024)Active
Gemcross Formulation Private Limited U46497UT2026PTC021844
Director13 Jul 20262026Active

Board colleagues of Ronak Agrawal

Directorship timeline

Open interactive timeline →
Aries Drugs Private Limited
Gemcross Formulation Private Limited
Premium access

Shareholding and investment profile for Ronak Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ronak Agrawal

Ronak Agrawal currently holds 2 directorships: Aries Drugs Private Limited (Director, since 02 May 2024, revenue ₹2.58 Cr (FY 2024)); Gemcross Formulation Private Limited (Director, since 13 Jul 2026).

Ronak Agrawal was first appointed on 02 May 2024 as Director at Aries Drugs Private Limited. The most recent appointment on record is 13 Jul 2026 at Gemcross Formulation Private Limited.

The current boards of Ronak Agrawal's companies include Amit Agarwal (Aries Drugs Private Limited), Hari Om Agarwal (Aries Drugs Private Limited), Madan Lal Agarwal (Aries Drugs Private Limited), Chitra Agrawal (Gemcross Formulation Private Limited), Mayank Agrawal (Gemcross Formulation Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available